Laurus Labs Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For LAURUSLABS, that strike is ₹2,020. Spot at ₹2,181.9 is 8.01% above max pain — possible downward gravitational pull into expiry.
Max Pain Level
The options market for Laurus Labs Limited (LAURUSLABS) shows a max‑pain strike at ₹2020. This is the price at which the combined loss of all open call and put writers would be minimized, acting as a magnet that often pulls the underlying toward it as expiry approaches.
Spot vs Max Pain Gap
The current spot price of ₹2181.9 sits about 8 % above the max‑pain level, indicating a modest out‑of‑the‑money call bias. Unless new directional pressure emerges, the gap suggests a pull‑back toward the ₹2020 zone as time decay accelerates.
Shift Signal
The max‑pain figure has shifted higher by ₹20 from yesterday, reflecting a slight move of option writer positioning toward higher strikes. This upward drift signals that writers are adjusting their exposure, perhaps anticipating a continued premium above the magnet but still leaving room for downward pressure.
Expiry Context
Max pain is derived from the aggregate open interest in calls and puts; as the contract nears its 2026‑11‑23 expiration, time decay erodes extrinsic value, making the convergence of spot to the pain point more likely. Historically, the final week often sees the underlying gravitate toward the pain strike, though the phenomenon remains a statistical tendency rather than a certainty.
Data Note
With 26 days left until expiry, the spot price sits roughly ₹162 above the max‑pain level, framing the short‑term price dynamics for LAURUSLABS.
Data as of 2026-10-28